146 related articles for article (PubMed ID: 12707978)
1. Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis.
Nagane Y; Utsugisawa K; Obara D; Yamagata M; Tohgi H
Muscle Nerve; 2003 May; 27(5):582-9. PubMed ID: 12707978
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis.
Utsugisawa K; Nagane Y; Suzuki S; Kondoh R
Muscle Nerve; 2007 Jul; 36(1):100-3. PubMed ID: 17471566
[TBL] [Abstract][Full Text] [Related]
3. Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with Myasthenia gravis.
Utsugisawa K; Nagane Y; Tohgi H
Muscle Nerve; 2000 Apr; 23(4):507-13. PubMed ID: 10716760
[TBL] [Abstract][Full Text] [Related]
4. NKT-associated markers and perforin in hyperplastic thymuses from patients with Myasthenia gravis.
Nagane Y; Utsugisawa K; Obara D; Tohgi H
Muscle Nerve; 2001 Oct; 24(10):1359-64. PubMed ID: 11562917
[TBL] [Abstract][Full Text] [Related]
5. [Distribution of CD44 highly-positive cells in relation to hyaluronic acid and basement membrane in myasthenia gravis thymus].
Nagane Y; Utsugisawa K
Rinsho Shinkeigaku; 1997 Sep; 37(9):790-5. PubMed ID: 9430992
[TBL] [Abstract][Full Text] [Related]
6. Altered intrathymic T-cell repertoire in human myasthenia gravis.
Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
[TBL] [Abstract][Full Text] [Related]
7. Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis.
Zhang J; Cohen-Kaminsky S; Berrih-Aknin S
Hum Antibodies Hybridomas; 1995; 6(4):153-60. PubMed ID: 8688498
[TBL] [Abstract][Full Text] [Related]
8. [Morphology of the thymus gland in children with myasthenia gravis].
Kop'eva TN; Sekamova SM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):13-7. PubMed ID: 2176031
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between pathogenesis of myasthenia gravis and thymus mature dendritic cells].
Xia Q; Liu WB; Feng HY; Chen ZG; Zhang Y; He XT
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(47):3349-51. PubMed ID: 19257967
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown.
Chilosi M; Iannucci A; Fiore-Donati L; Tridente G; Pampanin M; Pizzolo G; Ritter M; Bofill M; Janossy G
J Neuroimmunol; 1986 May; 11(3):191-204. PubMed ID: 3514666
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus.
Chen Z; Luo H; Peng Y; Cai L; Zhang J; Su C; Zou J
Ann Thorac Surg; 2011 Jan; 91(1):212-8. PubMed ID: 21172515
[TBL] [Abstract][Full Text] [Related]
12. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
13. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
[TBL] [Abstract][Full Text] [Related]
14. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
16. [The morphological and clinico-immunological characteristics of 2 types of myasthenia].
Zaĭrat'iants OV; Vetshev PS; Ippolitov IKh; Shkrob LO; Belokrinitskiĭ DV; Khodzhaev ZSh; Radenska-Lopovok SG
Arkh Patol; 1991; 53(8):22-7. PubMed ID: 1953371
[TBL] [Abstract][Full Text] [Related]
17. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia.
Berrih-Aknin S; Ruhlmann N; Bismuth J; Cizeron-Clairac G; Zelman E; Shachar I; Dartevelle P; de Rosbo NK; Le Panse R
Ann Neurol; 2009 Oct; 66(4):521-31. PubMed ID: 19847900
[TBL] [Abstract][Full Text] [Related]
18. Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis.
Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Itoyama Y
J Neuroimmunol; 2005 Oct; 167(1-2):186-9. PubMed ID: 16040133
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.
Cordiglieri C; Marolda R; Franzi S; Cappelletti C; Giardina C; Motta T; Baggi F; Bernasconi P; Mantegazza R; Cavalcante P
J Autoimmun; 2014 Aug; 52():74-89. PubMed ID: 24397961
[TBL] [Abstract][Full Text] [Related]
20. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
